Hospital Surgical Disinfectants Market Size, Share, and Trends 2024 to 2034

The global hospital surgical disinfectants market size was estimated at USD 402.19 million in 2022 and is projected to hit around USD 811.37 million by 2032, growing at a CAGR of 7.27% during the forecast period 2023 to 2032.

Key Takeaways

• On the basis of product, the chlorhexidine segment led the market and generated more than 26.50% revenue share in 2022.
• On the basis of end-user, the hospital segment held a revenue share of around 46% in 2022.
• On the basis of geography, the Asia Pacific region leads the market and accounted for more than 28% of revenue share in 2022.

Hospital Surgical Disinfectants Market Overview

The market for hospital surgical disinfectants is expanding due to several causes, including the high prevalence of chronic diseases, an increase in hospital-acquired infections (HAIs), an increase in surgical operations, an increase in the incidence of infectious diseases, and the most recent COVID-19 epidemic. The usage of surgical disinfectants in clinics, hospitals, and other medical institutions has significantly increased in response to the vital need for adequate sanitization during COVID-19. An updated list of disinfectants authorized for use against SARS-CoV-2 and surgical solutions, for instance, was issued by the Environmental Protection Agency (EPA) in March 2020. Hospitals are adopting preventive measures due to the outbreak of COVID-19 since doing so will help limit the disease's development. 

Additionally, HAIs are a significant concern for patients and healthcare personnel worldwide. The need for surgical equipment disinfection is expanding to reduce the risk of microbial contamination as hospitalizations and HAIs rise globally. According to WHO estimates, HCAIs affect hundreds of millions of individuals worldwide each year. Seven patients in affluent nations and ten in underdeveloped countries out of every 100 hospitalized patients have at least one HAI. The rising incidence of these disorders is anticipated to increase hospital surgical disinfectant demand in various healthcare facilities in order to prevent the spread of infection. Hospitals typically use disinfectant solutions to avoid contamination and reduce the incidence of HAIs, which is further expected to propel market growth. 

Furthermore, among the significant drivers likely to fuel the market expansion over the projected period are the increasing number of surgical procedures performed in hospitals and the rising awareness of infections and disorders. For instance, according to the Mölnlycke Health Care AB 2019 annual report, Europe performs almost 70 million surgical procedures annually. Similarly to this, the Healthcare Cost and Utilization Project (HCUP) indicate that in the United States in 2018, there were roughly 9,942,000 operations performed in ambulatory care settings. One of the fundamental criteria in healthcare units for surgeries is the use of solutions that are surgical disinfection. Because they stop or slow down the growth of germs on the skin, these products are more routinely used in hospitals and other medical settings to reduce the risk of infection during surgery and other treatments. As a result, these events will likely drive the market throughout the projection period.

Additionally, it is anticipated that rising endoscopic demand will increase the risk of contracting HAIs. According to 2018 research from the British Society of Gastroenterology and BMJ Publishing Group Ltd., the need for gastrointestinal endoscopy for bowel cancer screening in symptomatic patients has significantly increased. Throughout the forecast period, this is anticipated to boost the market for hospital surgical disinfectants.

Due to the high prevalence of hospital-acquired infections and the rising number of surgeries, the US led the market in 2020 with a share of revenue of over 80.0%. For instance, according to the Healthcare Information and Management Systems Society, every day in the United States, 1 out of every 25 people suffers from diseases that were acquired in hospitals. An increase in hospitals and the prevalence of infectious diseases, including dengue, tuberculosis, malaria, and typhoid, notably the present COVID-19 pandemic, are expected to drive the US market. Other factors driving the market expansion in the nation include a clearly defined regulatory framework, robust healthcare infrastructure, and a greater acceptance rate of preventive products in surgeries. During the anticipated period, this is likely to have a favorable effect on market growth.

In addition, it is projected that the prevalence of chronic diseases, such as diabetes, cancer, and other autoimmune disorders, will raise the hospitalization rate. Antimicrobial resistance and rising sedentary and unhealthy lifestyle adoption are two of the leading causes of the rising incidence of chronic diseases. The US National Center for Health Statistics estimates that 164 million Americans, including 81 million persons with multiple disorders, were living with a chronic disease in 2021. As a result of the expanding prevalence of chronic illnesses, the rate of hospital admissions has significantly increased. Surgical disinfectants are required in healthcare facilities to keep patients and inanimate objects germ-free. During the projected period, these factors are anticipated to fuel hospital surgical disinfectant demand.

Hospital Surgical Disinfectants Market Scope

Covid-19 Impact

The unexpected increase in COVID-19 instances across the globe has significantly boosted the market's potential prospects. During the pandemic, the increasing number of these coronavirus cases raised the need for proper sanitization in medical facilities. In addition, the use of surgical disinfectants has increased in various hospitals, clinics, and other healthcare facilities. As a result, the sudden rise in COVID-19 cases has increased the urgency of taking precautions to halt the disease's spread. Because of these measures, the market for hospital surgical disinfectants is expected to expand quickly over the coming years.

Product Insights

Due to the rising use of a formulation for pre-operative and pre-injection skin preparation, the chlorhexidine segment led the market in 2022 with a share of over 26.50%. The category is expanding as a result of the rising demand for chlorhexidine-based solutions that can be combined with other formulations, such as alcohol and iodine. The need for hand rubs such as sanitizers, which are efficient against various bacteria, has also increased, contributing to the rise in chlorhexidine demand.

Chlorhexidine is also anticipated to rise at the most significant CAGR from 2023 to 2032 due to the rising usage of surgical disinfectants in pre-injection and pre-operation skin preparation during surgical operations as raising awareness of their benefits. It is an effective and long-lasting antiseptic since it protects against SSIs, central line-associated bloodstream infections, or other comparable disorders. A wide range of antibacterial action, extremely infrequent side effects, and durable antimicrobial activity are all characteristics of CHG. Varying concentrations, such as 0.11%, 2.40%, and 4.60%, are used. The other significant reasons anticipated to propel the segment during the forecast period are an increase in awareness of the benefits of chlorhexidine for hygiene and an increase in surgical operations.

End-Use Insights

In 2022, the hospital sector held a revenue share of more than 46% of the market. Some of the main drivers propelling the hospital segment include an increase in surgical operations and the occurrence of infections. For instance, the CDC reports that approximately 1 in every 31 hospital patients had an infection. Using appropriate surgical disinfectants is crucial since it aids in stopping the spread of diseases. A report indicates that most hospitals and healthcare facilities are in Asia Pacific, fuelling industry expansion.

Over the projection period, the ambulatory surgical centers segment is anticipated to increase profitably. Growing public awareness of one-day procedures is a crucial driver of the segment's expansion. People in many nations choose ASCs since they are less expensive than hospitals for treatment due to the rising expense of medical operations. Due to the increased use of cutting-edge surgical equipment at ASCs, more people are being drawn to receive medical treatment there. Additionally, it is anticipated that the segment would be driven by an increase in the variety of operations that may be reimbursed. These elements should encourage the use of surgical disinfectants in ASCs, which will accelerate the segment's expansion over the forecast period.

Regional Insights

Asia Pacific was in the lead with a market share of over 28% in 2022 and is expected to grow at the highest rate between 2023 and 2032. This is related to factors like the high prevalence of hospital-acquired infections and improvements in healthcare infrastructure that promote the use of hospital surgical disinfectants. Additionally, it is anticipated that market expansion will be fueled by regulatory requirements to provide safe and high-quality healthcare services during the forecast period. For instance, the Chinese regulatory body, the National Medical Products Administration (NMPA), declared that it would expedite the registration of medical disinfectants that adhere to the EU, Japanese, and US requirements. Therefore, these factors are anticipated throughout the projected period to fuel market expansion.

The region's rising incidence of illnesses and procedures could further fuel market expansion. The highest rate of operations and surgeries in the area is another factor driving the industry. Asian nations, including India, China, and Thailand, are seeing increased medical tourism. For instance, the AIIMS New Delhi in India broke the record for the most surgeries performed in a calendar year with 1.97 lakh procedures. These nations' expanding healthcare systems have led to an increase in the consumption of hospital surgical disinfectants.

One of the key market drivers is the rise in healthcare spending in both the public and private sectors. A situation like this will likely spur the entry of several national and local businesses, boosting regional market expansion. Major market participants are also working to access untapped areas like Korea, China, and India, broadening the market's potential. Additionally, the region's fast-expanding hospital and laboratory population and the thriving medical tourism sector are fuelling the Asia Pacific region's market expansion. Such elements help the local economy even more.

Competitive Analysis

Two primary competitive strategies market participants employ significant R&D investments and product revisions. Manufacturers are introducing innovative solutions to boost sales and expand their clientele; a crucial aspect anticipated to fuel the market's expansion. Additionally, businesses are growing their distribution networks and expanding their corporate footprint in new markets through strategic alliances and agreements, likely to further fuel the demand for high-level disinfection services.

Additionally, the growing collaborations between regional and international companies will likely transform surgical disinfectants in general hospitals by spurring significant market growth. For instance, one of the top market expansion service providers, DKSH and Schülke&Mayr, formed a distribution deal in February 2019. According to the terms of the deal, DKSH will market and distribute a variety of Schülke's disinfection products in China. A situation like this will likely spur the entry of several local and foreign businesses, boosting market expansion. As a result, manufacturers are concentrating on growing their sales or business by diversifying their product lines or establishing new manufacturing facilities worldwide. Leading companies in the global market for hospital surgical disinfectants include:

• Ecolab
• 3M
• Sage Products LLC
• BD
• Johnson & Johnson
• Braun Melsungen AG
• Cardinal Health
• Kimberly-Clark Corporation
• Schülke&Mayr GmbH
• The Clorox Company

Segments Covered in the Report

(Note*: We offer reports based on sub-segments as well. Kindly, let us know if you are interested)

By Product

• Chlorhexidine
• Alcohols
• Octenidine
• Povidone-iodine
• Hydrogen Peroxide
• Others

By End-Use

• Clinics
• Hospitals
• Ambulatory Surgical Centers
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)